RBC on WAVE Life Sciences (WVE): 'we continue to like the setup'

April 28, 2026 2:58 PM

RBC Capital analyst Luca Issi reiterated an Outperform rating and $15.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found